BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020;369:m1067. [PMID: 32546500 DOI: 10.1136/bmj.m1067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Lv Z, Wu L, Lu Y, Liu S, Li Q. Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection Databases. Clin Rheumatol 2022. [PMID: 36121577 DOI: 10.1007/s10067-022-06377-8] [Reference Citation Analysis]
2 Zhang S, Zhang J, Li Y, Jiao J. From Suspicion to Diagnosis: Analysis on the Clinical Characteristics of 37 Cases of IgG4-Related Disease (IgG4-RD) in Northeast China. JIR 2022;Volume 15:4487-97. [DOI: 10.2147/jir.s367211] [Reference Citation Analysis]
3 Cai S, Hu Z, Chen Y, Zhong J, Dong L. Potential roles of non-lymphocytic cells in the pathogenesis of IgG4-related disease. Front Immunol 2022;13:940581. [DOI: 10.3389/fimmu.2022.940581] [Reference Citation Analysis]
4 Newell C, Kline GA, Joseph JT. The Curious Case of Hypopituitarism. J Neuropathol Exp Neurol 2022:nlac046. [PMID: 35751439 DOI: 10.1093/jnen/nlac046] [Reference Citation Analysis]
5 Zongfei J, Lingli C, Ying S, Lingying M, Lijuan Z, Dongmei L, Xiaomin D, Yingyong H, Huiyong C, Lili M, Lindi J. Clinical and pathological predictors of relapse in IgG4-related disease. Arthritis Res Ther 2022;24:106. [PMID: 35546243 DOI: 10.1186/s13075-022-02792-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu Q, Li B, Li Y, Wei Y, Huang B, Liang J, You Z, Li Y, Qian Q, Wang R, Zhang J, Chen R, Lyu Z, Chen Y, Shi M, Xiao X, Wang Q, Miao Q, Fang JY, Gershwin ME, Lian M, Ma X, Tang R. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut 2022;71:899-909. [PMID: 34035120 DOI: 10.1136/gutjnl-2020-323565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Faz-Muñoz D, Hinojosa-Azaola A, Mejía-Vilet JM, Uribe-Uribe NO, Rull-Gabayet M, Muñoz-Castañeda WR, Vargas-Parra NJ, Martín-Nares E. ANCA-associated vasculitis and IgG4-related disease overlap syndrome: a case report and literature review. Immunol Res 2022. [PMID: 35449491 DOI: 10.1007/s12026-022-09279-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu X, Shao C, Yu C, Huang H, Pan R, Xu K, Zhang X, Xu Z. Severe asthma as the initial clinical manifestation of IgG4-related disease: a retrospective clinical study. BMC Pulm Med 2022;22:141. [PMID: 35413899 DOI: 10.1186/s12890-022-01937-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang Y, Wang C, Shi L, Yang S, Liu Y, Luo J, Wang C. Clinical Characteristics and CD4+ T Cell Subsets in IgG4-Related Disease. Front Immunol 2022;13:825386. [DOI: 10.3389/fimmu.2022.825386] [Reference Citation Analysis]
10 Ireifej B, Dhamrah U, Song D, Bitar J, Jaiswal V, Nepal G, Pathak N, Freijat M. Cerebellar infarction as the initial presentation of IgG4‐related disease. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5614] [Reference Citation Analysis]
11 Kaneko N, Moriyama M, Maehara T, Chen H, Miyahara Y, Nakamura S. Orchestration of Immune Cells Contributes to Fibrosis in IgG4-Related Disease. Immuno 2022;2:170-84. [DOI: 10.3390/immuno2010013] [Reference Citation Analysis]
12 Hao FY, Yang FX, Bian HY, Zhao X. Immunoglobulin G4-related lymph node disease with an orbital mass mimicking Castleman disease: A case report. World J Clin Cases 2021; 9(35): 10999-11006 [DOI: 10.12998/wjcc.v9.i35.10999] [Reference Citation Analysis]
13 Liu J, Liu Y, Shen X, He Z, Yu T, Pang L, Jin X, Wang L. Clinicopathological characteristics of IgG4-related lung disease. BMC Pulm Med 2021;21:413. [PMID: 34911521 DOI: 10.1186/s12890-021-01781-3] [Reference Citation Analysis]
14 Delcros Q, Groh M, Nasser M, Kahn J, Cottin V. Steroid alternatives for managing eosinophilic lung diseases. Expert Opinion on Orphan Drugs 2021;9:205-18. [DOI: 10.1080/21678707.2021.2003777] [Reference Citation Analysis]
15 Ho RCW, Chan TSY, Au-Yeung R, Tang KHK, Hwang YY, Tse E, Kwong YL. Spectrum of B-cell neoplasms associated with immunoglobulin G4-related disease. Ann Hematol 2021. [PMID: 34767055 DOI: 10.1007/s00277-021-04675-w] [Reference Citation Analysis]
16 Della-Torre E, Lanzillotta M, Ramirez GA, Dagna L, Tresoldi M. Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply. Eur J Intern Med 2021:S0953-6205(21)00365-4. [PMID: 34711472 DOI: 10.1016/j.ejim.2021.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Olson CG, Olson NY. Hyper IgG4-Related Disease Presenting with Orbital Tumor and Immune Deficiency. Case Reports Immunol 2021;2021:9260051. [PMID: 34589241 DOI: 10.1155/2021/9260051] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhang P, Liu Z, Peng L, Zhou J, Wang M, Li J, Lu H, Hu C, Zhao L, Yang H, Wang Q, Fei Y, Zhang X, Zhao Y, Zeng X, Zhang W. Phenotype, function and clinical significance of innate lymphoid cells in immunoglobulin G4-related disease. Rheumatology (Oxford) 2021:keab610. [PMID: 34554231 DOI: 10.1093/rheumatology/keab610] [Reference Citation Analysis]
19 Wang G, Zhuo N, Luo X, Tian F, Wen Z, Li J. IgG4-Related Disease With Testicular Involvement: A Case Report and Review of Literature. Front Immunol 2021;12:717902. [PMID: 34447384 DOI: 10.3389/fimmu.2021.717902] [Reference Citation Analysis]
20 Mancuso G, Jofra T, Lanzillotta M, Aiuti A, Cicalese MP, di Colo G, Dagna L, Fousteri G, Della-Torre E. Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease. Rheumatology (Oxford) 2021;60:3947-9. [PMID: 33856429 DOI: 10.1093/rheumatology/keab344] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kakar F, Swaminathan S, Brown DA, Lin MW, McDonald D, Lee AYS. Restricted migration of polyclonal IgG on immunofixation gel electrophoresis in a case of IgG4-related disease. Pathology 2021:S0031-3025(21)00416-5. [PMID: 34389173 DOI: 10.1016/j.pathol.2021.05.092] [Reference Citation Analysis]
22 Han X, Zhang P, Li J, Liu Z, Lu H, Luo X, Pan B, Lian X, Zeng X, Zhang W, Zeng X. Clinical features and treatment efficacy for IgG4-related thyroiditis. Orphanet J Rare Dis 2021;16:324. [PMID: 34289855 DOI: 10.1186/s13023-021-01942-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Pötter-Lang S, Ba-Ssalamah A, Bastati N, Messner A, Kristic A, Ambros R, Herold A, Hodge JC, Trauner M. Modern imaging of cholangitis. Br J Radiol 2021;94:20210417. [PMID: 34233488 DOI: 10.1259/bjr.20210417] [Reference Citation Analysis]
24 Novatti EB, Cucchiaro N, Soruco M, Laborié MV, Caeiro F, Balderramo D, Baenas DF. Gastric inflammatory pseudotumor as a manifestation of IgG4-related disease. Gastroenterol Hepatol 2021:S0210-5705(21)00213-2. [PMID: 34252486 DOI: 10.1016/j.gastrohep.2021.06.008] [Reference Citation Analysis]
25 On W, Huggett MT. European Guideline on IgG4-related digestive disease: UEG and SGF evidence-based recommendations. Frontline Gastroenterol 2022;13:171-4. [DOI: 10.1136/flgastro-2021-101884] [Reference Citation Analysis]
26 Moussiegt A, Müller R, Ebbo M, Grados A, Graveleau J, Ackermann F, Bachmeyer C, Bernit E, Blanche P, Canoui E, Chaix F, Costedoat-Chalumeau N, Groote P, Etienne N, Fior R, Flamarion E, Kennel T, Launay D, Lerolle N, Limal N, Loustau V, Menage E, Moulis G, Papo T, Pouchot J, Quemeneur T, Roumier M, Tchérakian C, Lefèvre G, Rebours V, Kahn JE, Schleinitz N, Groh M; CEREO., French IgG4-RD Study Group. IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes. Autoimmun Rev 2021;20:102889. [PMID: 34237420 DOI: 10.1016/j.autrev.2021.102889] [Reference Citation Analysis]
27 Lanzillotta M, Della-Torre E, Wallace ZS, Stone JH, Karadag O, Fernández-Codina A, Arcidiacono PG, Falconi M, Dagna L, Capurso G. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis. Pancreatology 2021:S1424-3903(21)00494-4. [PMID: 34244040 DOI: 10.1016/j.pan.2021.06.009] [Reference Citation Analysis]
28 Zhang P, Zhang Y, Pan M, Liu Z, Li J, Peng L, Zhou J, Hu C, Liu S, Zeng X, Ge W, Zhang W. Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage. J Autoimmun 2021;122:102650. [PMID: 34107438 DOI: 10.1016/j.jaut.2021.102650] [Reference Citation Analysis]
29 Skillington SA, Ogden MA. IgG4-Related Disease and the Salivary Glands: A Review of Pathophysiology, Diagnosis, and Management. Otolaryngol Clin North Am 2021;54:497-508. [PMID: 34024478 DOI: 10.1016/j.otc.2021.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 López-Fernández J, García Plaza G, García Martín CM, de la Cruz Cuadrado C, Larrea Y Olea FJ, Hernández Hernández JR. IgG4-related cholecystitis mimicking gallbladder carcinoma; the challenge of a preoperative diagnosis. Gastroenterol Hepatol 2021:S0210-5705(21)00144-8. [PMID: 34023474 DOI: 10.1016/j.gastrohep.2021.03.003] [Reference Citation Analysis]
31 Della-Torre E, Lanzillotta M, Germanò T, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease. Semin Arthritis Rheum 2021;51:761-5. [PMID: 34144386 DOI: 10.1016/j.semarthrit.2021.04.021] [Reference Citation Analysis]
32 Berrier A, Gomez E, Essari LA, Soler J, Petit I, Pierre C, Chabot F, Chaouat A. [IgG4-Related Disease: A rare cause of severe interstitial lung disease]. Rev Mal Respir 2021;38:530-4. [PMID: 33965265 DOI: 10.1016/j.rmr.2021.02.071] [Reference Citation Analysis]
33 Qing P, Lu C, Liu Z, Wen X, Chen B, Lin Z, Ma Y, Zhao Y, Liu Y, Tan C. IgG4-Related Disease With Tuberculosis: A Case Report and Retrospective Review of Patients in a Single Center. Front Immunol 2021;12:652985. [PMID: 33968053 DOI: 10.3389/fimmu.2021.652985] [Reference Citation Analysis]
34 Haan EA, Chamalaun FH, Chamuleau SAJ, Arnolda LF, Slavotinek JP, Wise NC, Gunawardane DN, Schwarze U, Byers PH, Gabb GM. Marfan syndrome resulting from a rare pathogenic FBN1 variant, ascertained through a proband with IgG4-related arteriopathy. Am J Med Genet A 2021;185:2180-9. [PMID: 33878224 DOI: 10.1002/ajmg.a.62218] [Reference Citation Analysis]
35 Cargill T, Culver EL. The Role of B Cells and B Cell Therapies in Immune-Mediated Liver Diseases. Front Immunol 2021;12:661196. [PMID: 33936097 DOI: 10.3389/fimmu.2021.661196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Akiyama M, Suzuki K, Yoshimoto K, Yasuoka H, Kaneko Y, Takeuchi T. Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease. Front Immunol 2021;12:651357. [PMID: 33936071 DOI: 10.3389/fimmu.2021.651357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Lanzillotta M, Fernàndez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E. Emerging therapy options for IgG4-related disease. Expert Rev Clin Immunol 2021;17:471-83. [PMID: 33689549 DOI: 10.1080/1744666X.2021.1902310] [Reference Citation Analysis]
38 Tanaka Y, Takikawa T, Kume K, Kikuta K, Hamada S, Miura S, Yoshida N, Hongo S, Matsumoto R, Sano T, Ikeda M, Unno M, Masamune A. IgG4-related Diaphragmatic Inflammatory Pseudotumor. Intern Med 2021;60:2067-74. [PMID: 33518577 DOI: 10.2169/internalmedicine.6589-20] [Reference Citation Analysis]
39 Rovati L, Kaneko N, Pedica F, Monno A, Maehara T, Perugino C, Lanzillotta M, Pecetta S, Stone JH, Doglioni C, Manfredi AA, Pillai S, Della-Torre E. Mer tyrosine kinase (MerTK) as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease. Rheumatology (Oxford) 2021:keab096. [PMID: 33512463 DOI: 10.1093/rheumatology/keab096] [Reference Citation Analysis]
40 Behzadi F, Suh CH, Jo VY, Shanmugam V, Morgan EA, Guenette JP. Imaging of IgG4-Related Disease in the Head and Neck: A Systematic Review, Case Series, and Pathophysiology Update. J Neuroradiol 2021:S0150-9861(21)00031-6. [PMID: 33516733 DOI: 10.1016/j.neurad.2021.01.006] [Reference Citation Analysis]
41 Della-Torre E, Lanzillotta M, Campochiaro C, Di-Colo G, Mancuso G, Capurso G, Falconi M, Dagna L. Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study. Eur J Intern Med 2021;84:63-7. [PMID: 33386207 DOI: 10.1016/j.ejim.2020.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Quattrocchio G, Barreca A, Demarchi A, Fenoglio R, Ferro M, Del Vecchio G, Massara C, Rollino C, Sciascia S, Roccatello D. Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement. Immunol Res 2020;68:340-52. [PMID: 33174125 DOI: 10.1007/s12026-020-09163-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rampi A, Lanzillotta M, Mancuso G, Vinciguerra A, Dagna L. IgG4-Related Disease of the Oral Cavity. Case Series from a Large Single-Center Cohort of Italian Patients. Int J Environ Res Public Health 2020;17:E8179. [PMID: 33167472 DOI: 10.3390/ijerph17218179] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Yang DH, Wang YH, Pan LF, Wei JC. Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren's Syndrome. J Clin Med 2020;9:E3469. [PMID: 33126508 DOI: 10.3390/jcm9113469] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]